tiprankstipranks
Trending News
More News >
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (DE:6NQ)
FRANKFURT:6NQ
Germany Market
Advertisement

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (6NQ) Cash flow

Compare
0 Followers

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Cash Flow

DE:6NQ's free cash flow for Q1 2025 was zł5.60M. For the 2025 fiscal year, DE:6NQ's free cash flow was decreased by zł89.83M and operating cash flow was zł8.68M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
zł 13.73Mzł -5.34Mzł 2.95Mzł -3.28Mzł 343.00K
Investing Cash Flow
zł -25.89Mzł -72.90Mzł -26.97Mzł -4.49Mzł -2.02M
Financing Cash Flow
zł 10.75Mzł 53.33Mzł 36.82Mzł 20.22Mzł 2.86M
End Cash Position
zł 760.00Kzł 2.17Mzł 27.09Mzł 14.30Mzł 1.84M
Free Cash Flow
zł -28.11Mzł -117.95Mzł -33.81Mzł -21.71Mzł -1.68M
Currency in PLN

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis